These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3880666

  • 1. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
    Douay L, Gorin NC, Lopez M, Casellas P, Liance MC, Jansen FK, Voisin GA, Baillou C, Laporte JP, Najman A.
    Cancer Res; 1985 Jan; 45(1):438-41. PubMed ID: 3880666
    [Abstract] [Full Text] [Related]

  • 2. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM.
    Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
    [Abstract] [Full Text] [Related]

  • 3. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 4. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease.
    Fauser AA, Shustik C, Langleben A, Laurent G, Kanz L, Spurll GM, Price G, Ahlgren PD, Cooper BA.
    Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672
    [Abstract] [Full Text] [Related]

  • 5. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
    Stong RC, Youle RJ, Vallera DA.
    Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.
    Shannon KM, Ring DB, Houston LL, Schaffner V, Naylor J, Torkildson JC, Reid SA, Larrick J.
    Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286
    [Abstract] [Full Text] [Related]

  • 7. Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
    Gorin NC, Douay L, Laporte JP, Lopez M, Zittoun R, Rio B, David R, Stachowiak J, Jansen J, Cazellas P.
    Cancer Treat Rep; 1985 Sep; 69(9):953-9. PubMed ID: 3896482
    [Abstract] [Full Text] [Related]

  • 8. Immunotoxin depletion of T cells and its effect on hematopoietic progenitor cells in human cord blood.
    Xu M, Lu S, Shen B, Li Y.
    Chin Med J (Engl); 2001 Apr; 114(4):355-9. PubMed ID: 11780453
    [Abstract] [Full Text] [Related]

  • 9. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
    Krönke M, Schlick E, Waldmann TA, Vitetta ES, Greene WC.
    Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
    [Abstract] [Full Text] [Related]

  • 10. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
    Kernan NA, Knowles RW, Burns MJ, Broxmeyer HE, Lu L, Lee HM, Kawahata RT, Scannon PJ, Dupont B.
    J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
    [Abstract] [Full Text] [Related]

  • 11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 12. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.
    Leonard JE, Taetle R, To D, Rhyner K.
    Blood; 1985 May; 65(5):1149-57. PubMed ID: 3888307
    [Abstract] [Full Text] [Related]

  • 13. Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin.
    Casellas P, Canat X, Fauser AA, Gros O, Laurent G, Poncelet P, Jansen FK.
    Blood; 1985 Feb; 65(2):289-97. PubMed ID: 3871341
    [Abstract] [Full Text] [Related]

  • 14. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen.
    Youle RJ, Uckun FM, Vallera DA, Colombatti M.
    J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613
    [Abstract] [Full Text] [Related]

  • 15. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo.
    Schmidberger H, King L, Lasky LC, Vallera DA.
    Cancer Res; 1990 Jun 01; 50(11):3249-56. PubMed ID: 1692258
    [Abstract] [Full Text] [Related]

  • 16. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
    Boswell HS, Wade PM, Quesenberry PJ.
    J Immunol; 1984 Dec 01; 133(6):2940-9. PubMed ID: 6149245
    [Abstract] [Full Text] [Related]

  • 17. Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohammed R.
    Exp Hematol; 1997 Jun 01; 25(6):471-7. PubMed ID: 9197323
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G, Runge W, Jansen FK, Vallera DA.
    Cancer Res; 1985 Mar 01; 45(3):1328-36. PubMed ID: 3971376
    [Abstract] [Full Text] [Related]

  • 19. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar 01; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 20. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y, Feyens AM, Sekhavat M, Agaliotis D, Canon JL, Symann ML.
    Cancer Res; 1989 Sep 15; 49(18):5058-61. PubMed ID: 2548708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.